In gallbladder cancer (GBC), Minghui Hou et al. (2025) [45] delineated an EndMT-associated endothelial subtype, CD34+CD90+ ECs, and demonstrated its relevance to tumor progression and patient prognosis. This evidence concerns the gene CD34 and neoplasm.